openPR Logo
Press release

The Global Alzheimer's Disease Therapeutics and Diagnostics Market to Reach $16928 Million by 2027

06-11-2020 02:39 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Triton Market Research

Global Alzheimer's Disease Therapeutics and Diagnostics Market

Global Alzheimer's Disease Therapeutics and Diagnostics Market

Triton Market Research, in its report on the global Alzheimer's disease therapeutics and diagnostics market, has concluded that the industry, which generated $8950 million in 2018, is estimated to flourish at a CAGR of 7.78% by the year 2027.

A study by Triton Market Research with the title 'Global Alzheimer's Disease Therapeutics and Diagnostics,' covers the Global Analysis and Forecast for 2019-2027 by Therapeutics and Diagnostics (Therapeutics [Disease Stage {Late stage, Early-stage, Prodromal}, Generic & Branded {Branded, Generic}, Drugs {Marketed, Pipeline}], Diagnostics [Positron Emission Tomography, Magnetic Resonance Imaging, Lumbar Puncture Test, Electroencephalography, Computed Tomography, Other Diagnostics]), and by Geographical Region (Asia-Pacific, North America, Europe, Latin America, Middle East and Africa).

Alzheimer's disease is a progressive neurodegenerative disorder that mostly affects the geriatric population, above the age of 65. It is characterized by dementia, agitation, depression, anxiety, insomnia and other symptoms.

Request Free Sample of the Global Alzheimer's Disease Therapeutics and Diagnostics Market Report @ https://www.tritonmarketresearch.com/reports/alzheimer%E2%80%99s-disease-therapeutics-and-diagnostic-market#request-free-sample

According to the report, the global Alzheimer's disease therapeutics and diagnostics market is likely to reach $144734 million by 2027, proliferating at a CAGR of 7.78% in the forecasting period 2019-2027. Growth in the prevalence of Alzheimer's disease across the world is the basic factor driving the global market growth. The swelling geriatric population and the substantial investments made by the government in the field of research and development for Alzheimer's disease are other drivers of the global market. However, strict government regulations for drug development and commercialization and the huge cost of the treatment of Alzheimer's disease are impeding the market growth.

The global Alzheimer's disease therapeutics and diagnostics market is segmented on the basis of therapeutics and diagnostics. Based on therapeutics, the Alzheimer's disease therapeutics and diagnostics market is divided into disease stage, generic & branded and drugs. Within the disease stage, it is further divided into the late stage, early-stage, and prodromal stage; while within generic & branded, the market is segmented into branded and generic. And within drugs, it is segmented into marketed and pipeline drugs. According to diagnostics, the market is segmented into positron emission tomography, magnetic resonance imaging, lumbar puncture test, electroencephalography, computed tomography and other diagnostics.

Considering the regional landscape, the Asia-Pacific is anticipated to be the fastest-growing region for Alzheimer's disease therapeutics and diagnostics market during the estimated period. The growing geriatric population in the Asian countries like India, China, South Korea, Japan, Australia and New Zealand are the main factors driving the regional market growth.

On the other hand, North America is estimated to be the largest Alzheimer's disease therapeutics and diagnostics market in the projected period. The growing awareness and the rising demand for better drug coverage in Canada are driving the growth of Alzheimer's disease therapeutics and diagnostics market growth.

AbbVie Inc, Amarantus Bioscience Holdings Inc, Baxter, Biogen, Cognoptix Inc, Piramal Enterprises Ltd, Siemens Healthcare Private Ltd and Sun Pharmaceutical Industries Ltd are some of the companies in the Alzheimer's disease therapeutics and diagnostics market.

Purchase this Report @ https://www.tritonmarketresearch.com/reports/alzheimer%E2%80%99s-disease-therapeutics-and-diagnostic-market#purchase-option

Question & Answer: Alzheimer's Disease Therapeutics and Diagnostics Market

Question 1: What are the drivers of the global Alzheimer's disease therapeutics and diagnostics market?
Answer: The growing prevalence of Alzheimer's disease across the world is the basic factor driving the global market growth. The swelling geriatric population and the substantial investments made by the government in the field of research and development for Alzheimer's disease are other drivers of the global market.

Question 2: Which factors are impeding the growth of the Alzheimer's disease therapeutics and diagnostics market?
Answer: Strict government regulations for drug development and commercialization and the huge cost of the treatment of Alzheimer's disease are impeding the market growth of Alzheimer's disease therapeutics and diagnostics market.

Question 3: How are the Asia-Pacific and North America impacting Alzheimer's disease therapeutics and diagnostics market outlook?
Answer: Considering the regional landscape, Asia-Pacific is anticipated to be the fastest-growing region for Alzheimer's disease therapeutics and diagnostics market during the estimated period. The growing geriatric population in Asian countries like India, China, South Korea, Japan, Australia and New Zealand are the main factors driving the regional market growth.

On the other hand, North America is estimated to be the largest Alzheimer's disease therapeutics and diagnostics market in the projected period. The growing awareness and the rising demand for better drug coverage in Canada are driving the growth of Alzheimer's disease therapeutics and diagnostics market growth.

Question 4: Which are some of the companies in the Alzheimer's disease therapeutics and diagnostics market?
Answer: AbbVie Inc, Amarantus Bioscience Holdings Inc, Baxter, Biogen, Cognoptix Inc, Piramal Enterprises Ltd, Siemens Healthcare Private Ltd and Sun Pharmaceutical Industries Ltd are some of the companies in the Alzheimer's disease therapeutics and diagnostics market.

Related Report:
Global Hearing Aids Market

The global hearing aids market is estimated to grow at $14918.7 million by 2027, with a CAGR of 6.89% over the predicted period 2019-2028. The significant potential for hearing aids in developing economies, including India, China, Russia, South Korea and New Zealand, is driving the global market growth. The growing geriatric population, coupled with technological advancements in the hearing aids field, including wireless & Bluetooth and noise reduction circuits, is also aiding the growth of the hearing aids market.

The incorporation of lithium-ion batteries in hearing aids devices is likely to create new business opportunities for the market. In addition, the increasing hearing loss cases resulting from various reasons is expected to boost the adoption of the hearing aids devices market.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Alzheimer's Disease Therapeutics and Diagnostics Market to Reach $16928 Million by 2027 here

News-ID: 2072578 • Views: 617

More Releases from Triton Market Research

Global Flexible Packaging Market Estimated to Gain $350.17 Billion in Revenue by …
A recent study by Triton Market Research titled Global Flexible Packaging Market discusses the Global Analysis and Forecasts by Type (Gusseted Bags, Stand-Up Pouches, Wraps, Flat Pouches, Rollstock, Wicketed Bags), Application (Cosmetics, Pharmaceuticals, Food & Beverage, Others), Printing Technology (Rotogravure, Digital Printing, Flexography, Others), Raw Material (Bioplastic, Aluminum, Paper, Plastic), and Geography (Latin America, Europe, Asia-Pacific, Middle East and Africa, and North America). Flexible packaging is a customization solution used for
Global Smoke Detector Market Estimated to Gain $2783.82 Million by 2028
A recent study by Triton Market Research titled 'Global Smoke Detector Market,' consists of the Global Analysis and Forecasts by End-user (Telecommunication, Manufacturing, Automotive, Commercial, Oil & Gas, Residential, Other End-users), Type (Dual Sensor, Photoelectric, Ionization, Other Types), Power Source (Hardwired Smoke Detectors, Battery-powered Smoke Detectors, Others {Hardwired with Battery}), and Regional Outlook (Europe, Latin America, Asia-Pacific North America, and Middle East and Africa). Request Free Sample of the Global Smoke
Global Renewable Methanol Market Evaluated to Grow at $4296.33 Million by 2028
A recent study by Triton Market Research titled 'Global Renewable Methanol Market' by End-user (Transportation, Power Generation, Chemical, Other End-users), Feedstock (Agricultural Waste, Forestry Residues, CO2 Emissions, Municipal Solid Waste, Other Feedstocks), Application (Solvents, DME & MTBE, Formaldehyde, Gasoline, Other Applications), and Geography (Latin America, North America Asia-Pacific, Europe, Middle East and Africa). Renewable methanol is a liquid produced from renewable energy and is used largely as a substitute for
Electric Power Distribution Automation Systems Market Analysis for 2028
According to Triton's report, the global electric power distribution automation systems market, which attained $30053.37 million in 2021, is expected to register progress at 7.05% of CAGR by 2028. A recent study by Triton Market Research titled 'Global Electric Power Distribution Automation Systems Market' by Implementation (Feeder Automation, Substation Automation, Consumer Automation), End-user (Industrial, Commercial, Residential), and Regional Outlook (Europe, the Middle East and Africa, Asia-Pacific, North America, and Latin America).

All 5 Releases


More Releases for Alzheimer

Alzheimer Disease Drugs Market Global Trends, Market Share, Industry Size, Growt …
Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer's treatment is a high risk, high reward market. Drugs currently
Anti-β-Alzheimer Therapies Market Analysis with Technological Advancement and G …
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Anti-β-Alzheimer Therapies That Cut Attacks Hailed As 'huge Deal'
Alzheimer disease (AD) is a type of dementia that affects memory, thinking, language and behavior. Increasing age and high number of people suffering from Alzheimer's with age 65 and older are the major risk factors for progression of this disorder. It starts with mild symptoms and ends with severe brain damage in which individuals lose the ability to carry on a conversation and respond to their environment. According to Alzheimer
Alzheimer Diagnostic Tests Market - Medical Devices Pipeline Assessment, 2017 | …
"The Latest Research Report Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Alzheimer Diagnostic Tests Market GlobalData's Medical Devices sector report, Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Alzheimer Diagnostic Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,
Global Alzheimer Market Report: 2015 Edition | Now Available at Researchmoz.us
Researchmoz added Most up-to-date research on "Global Alzheimer Market Report: 2015 Edition" to its huge collection of research reports. Alzheimer’s disease is defined as an advanced neurological disorder that increasingly deprives patients of their memory and ability to carry out daily activities. As it grows in a human brain, individuals are likely to practice difficulties in linguistic, agility and insight along with negative changes in the character and performance such as